Home
Sign in
Listen in app
Studying Olutasidenib in Relapsed/Refractory Acute Myeloid Leukemia With Jorge Cortes, MD
Oncology Data Advisor®
Likes
Reposts
In albums
In playlists
Related
ASH Annual Meeting 2022: Leukemias and Myeloproliferative Neoplasms
Oncology Data Advisor®
0
Playlist
2y
Showing all playlists 🏁
Home
Home
Feed
Feed
Search
Search
Library
Library
Download
Download